Tomohiko Umei
About
In The Last Decade
Tomohiko Umei
19 papers receiving 707 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 584
- Surgery 373
- Cardiology and Cardiovascular Medicine 86
- Cellular and Molecular Neuroscience 78
- Biomaterials 63
Countries citing papers authored by Tomohiko Umei
This map shows the geographic impact of Tomohiko Umei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiko Umei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiko Umei more than expected).
Fields of papers citing papers by Tomohiko Umei
This network shows the impact of papers produced by Tomohiko Umei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiko Umei. The network helps show where Tomohiko Umei may publish in the future.
Co-authorship network of co-authors of Tomohiko Umei
This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiko Umei. A scholar is included among the top collaborators of Tomohiko Umei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiko Umei. Tomohiko Umei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 23 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 12 | |
| 9 | 24 | |
| 10 | 8 | |
| 11 | 0 | |
| 12 | 17 | |
| 13 | 7 | |
| 14 | 4 | |
| 15 | 17 | |
| 16 | 121 | |
| 17 | 1 | |
| 18 | 248 | |
| 19 | 6 | |
| 20 | [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia]. | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.